Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 100951-101000 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04340843
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
PHASE2
Active, not recruiting
19 participants
Started: Sep 8, 2020 · Completed: Jun 17, 2026
3 conditions
1 sponsor
39 locations
NCT04875728
The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma
PHASE1
Active, not recruiting
20 participants
Started: Sep 8, 2020 · Completed: Feb 2, 2027
14 conditions
2 sponsors
1 location
NCT04304651
Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism
NA
Recruiting
1,276 participants
Started: Sep 8, 2020 · Completed: Sep 8, 2030
1 condition
4 sponsors
20 locations
NCT04548830
Safety of Lung Cryobiopsy in People With Cancer
PHASE2
Active, not recruiting
100 participants
Started: Sep 8, 2020 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT04653740
Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer
NA
Active, not recruiting
25 participants
Started: Sep 8, 2020 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT04457258
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
EARLY_PHASE1
Active, not recruiting
18 participants
Started: Sep 8, 2020 · Completed: Jul 21, 2027
3 conditions
2 sponsors
1 location
NCT04242134
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
NA
Active, not recruiting
784 participants
Started: Sep 8, 2020 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04986748
Using QPOP to Predict Treatment for Sarcomas and Melanomas
N/A
Recruiting
100 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT04608032
Neuropsychological Assessment of Remediation for Cognitive Impairments in Schizophrenia
NA
Recruiting
70 participants
Started: Sep 8, 2020 · Completed: Dec 1, 2024
1 condition
1 sponsor
2 locations
NCT04511234
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
NA
Recruiting
279 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2026
3 conditions
1 sponsor
20 locations
NCT06187454
Transcranial Direct Current Stimulation for Depression
NA
Recruiting
30 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04390737
Evaluate the Safety and Clinical Activity of HH2853
PHASE1/PHASE2
Recruiting
254 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2025
4 conditions
1 sponsor
25 locations
NCT04547543
Follow-up of Apneic Patients by Visio-consultation
NA
Recruiting
250 participants
Started: Sep 8, 2020 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT04699734
Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy
NA
Recruiting
16 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05395533
A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.
PHASE1
Active, not recruiting
147 participants
Started: Sep 8, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
6 locations
NCT04535479
Dry Needling for Spasticity in Stroke
NA
Active, not recruiting
32 participants
Started: Sep 8, 2020 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT04494009
PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy
PHASE2
Active, not recruiting
110 participants
Started: Sep 7, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04226339
Evaluation of Walking Analysis After a Total Knee Arthroplasty With Kinematic Alignment Versus Mechanical Alignment
NA
Recruiting
104 participants
Started: Sep 7, 2020 · Completed: Mar 7, 2029
1 condition
1 sponsor
1 location
NCT04525950
Robotized Navigation Compared to Conventional Technique in Total Knee Replacement
NA
Active, not recruiting
214 participants
Started: Sep 7, 2020 · Completed: Dec 31, 2031
2 conditions
3 sponsors
2 locations
NCT05304988
Development and Validation of the EFT for Adolescents With Cancer
N/A
Recruiting
400 participants
Started: Sep 7, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04547309
Research for the Molecular Imaging of the HER2 Targeting Tracer
NA
Recruiting
200 participants
Started: Sep 7, 2020 · Completed: Aug 30, 2026
1 condition
3 sponsors
1 location
NCT04121065
Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)
N/A
Recruiting
150 participants
Started: Sep 7, 2020 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT03597321
Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML
PHASE2
Active, not recruiting
124 participants
Started: Sep 7, 2020 · Completed: May 31, 2028
1 condition
1 sponsor
1 location
NCT04081246
Transurethral Modified En Bloc Resection For Large Bladder Tumours.
NA
Recruiting
30 participants
Started: Sep 7, 2020 · Completed: Sep 30, 2024
3 conditions
1 sponsor
1 location
NCT04677920
The Healthy Cookie Energy Study: Understanding How Healthy Cookies Affect Mitochondrial Biology
NA
Active, not recruiting
24 participants
Started: Sep 7, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04295538
Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)
PHASE2
Active, not recruiting
60 participants
Started: Sep 6, 2020 · Completed: Jan 31, 2026
1 condition
1 sponsor
41 locations
NCT04537156
Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
PHASE3
Active, not recruiting
9,327 participants
Started: Sep 5, 2020 · Completed: Dec 31, 2027
3 conditions
3 sponsors
2 locations
NCT04167527
Endovascular Therapy for Low NIHSS Ischemic Strokes
PHASE2/PHASE3
Active, not recruiting
143 participants
Started: Sep 5, 2020 · Completed: Sep 30, 2025
1 condition
5 sponsors
34 locations
NCT04385290
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
PHASE1/PHASE2
Recruiting
214 participants
Started: Sep 4, 2020 · Completed: Apr 30, 2028
1 condition
3 sponsors
21 locations
NCT04310670
Integrated Treatment in FND (Functional Neurological Disorders)
NA
Recruiting
30 participants
Started: Sep 4, 2020 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04159675
Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts
N/A
Recruiting
20 participants
Started: Sep 4, 2020 · Completed: Apr 4, 2026
1 condition
1 sponsor
1 location
NCT04258137
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
NA
Recruiting
332 participants
Started: Sep 4, 2020 · Completed: Dec 1, 2027
2 conditions
1 sponsor
6 locations
NCT04195347
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
PHASE1/PHASE2
Recruiting
42 participants
Started: Sep 4, 2020 · Completed: Dec 31, 2027
1 condition
2 sponsors
2 locations
NCT04387916
A Study of KC1036 in Patients with Advanced Solid Tumors
PHASE1
Recruiting
207 participants
Started: Sep 4, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT04550442
Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
PHASE1/PHASE2
Active, not recruiting
34 participants
Started: Sep 4, 2020 · Completed: Oct 31, 2025
5 conditions
3 sponsors
1 location
NCT05266144
Atrial Fibrillation Patients Treated With Catheter Ablation
N/A
Recruiting
300 participants
Started: Sep 4, 2020 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04541056
Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae
NA
Active, not recruiting
60 participants
Started: Sep 4, 2020 · Completed: Feb 28, 2026
3 conditions
4 sponsors
3 locations
NCT04355689
Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome
PHASE1/PHASE2
Active, not recruiting
49 participants
Started: Sep 3, 2020 · Completed: Aug 31, 2025
1 condition
2 sponsors
4 locations
NCT05478876
Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract
NA
Recruiting
9 participants
Started: Sep 3, 2020 · Completed: Sep 30, 2027
2 conditions
1 sponsor
1 location
NCT04554927
Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer
NA
Recruiting
438 participants
Started: Sep 3, 2020 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04353375
Phase 2 Study of HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma
PHASE2
Recruiting
128 participants
Started: Sep 3, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04673955
BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
N/A
Recruiting
500 participants
Started: Sep 3, 2020 · Completed: Jan 31, 2027
1 condition
4 sponsors
70 locations
NCT04039763
RT-CGM in Young Adults at Risk of DKA
NA
Recruiting
20 participants
Started: Sep 3, 2020 · Completed: Jun 30, 2022
6 conditions
2 sponsors
1 location
NCT03935295
Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis
PHASE4
Recruiting
90 participants
Started: Sep 3, 2020 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT04192136
NAD+ and Exercise in FA
NA
Active, not recruiting
80 participants
Started: Sep 3, 2020 · Completed: Feb 7, 2026
1 condition
2 sponsors
1 location
NCT04442022
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
PHASE2/PHASE3
Recruiting
501 participants
Started: Sep 3, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
57 locations
NCT05402085
N=1 Trials of Individual Variability in Post-prandial Glycemic Responses to Diets of Varying Macronutrient Composition
NA
Active, not recruiting
120 participants
Started: Sep 3, 2020 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04257500
Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/obese Women with PCOS
PHASE4
Recruiting
28 participants
Started: Sep 3, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04548817
Neurocutaneous Melanocytosis Registry
N/A
Recruiting
100 participants
Started: Sep 3, 2020 · Completed: Sep 3, 2027
3 conditions
1 sponsor
2 locations
NCT04602468
Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)
PHASE4
Active, not recruiting
237 participants
Started: Sep 3, 2020 · Completed: Jul 1, 2029
5 conditions
12 sponsors
7 locations
Previous
1
More pages
2017
2018
2019
2020
2021
2022
2023
More pages
2369
Next